Salah-Eddine Bentebibel

Statistics

Publications

Citations

4.3K

H-Index

Active since

2011

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Baylor University

Icahn School of Medicine at Mount Sinai

Nektar Therapeutics (United States)

Baylor Institute for Rehabilitation

Salah-Eddine Bentebibel is an author at The University of Texas MD Anderson Cancer Center specializing in immunology, life sciences, and cancer immunology.

ORCID

Publications per year

2011–2024

Publications

Human Blood CXCR5+CD4+ T Cells Are Counterparts of T Follicular Cells and Contain Specific Subsets that Differentially Support Antibody Secretion

Rimpei Morita, Nathalie Schmitt, Salah-Eddine Bentebibel et al. · Immunity · 2011 · 1.6K citations · Full text

Life Sciences, Cell Biology, Immunology +15

Induction of ICOS + CXCR3 + CXCR5 + T H Cells Correlates with Antibody Responses to Influenza Vaccination

Salah-Eddine Bentebibel, Santiago M. C. Lopez, Gerlinde Obermoser et al. · Science Translational Medicine · 2013 · 614 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

The cytokine TGF-β co-opts signaling via STAT3-STAT4 to promote the differentiation of human TFH cells

Nathalie Schmitt, Yang Liu, Salah-Eddine Bentebibel et al. · Nature Immunology · 2014 · 363 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +14

Interleukin-6 blockade abrogates immunotherapy toxicity and promotes tumor immunity

Yared Hailemichael, Daniel H. Johnson, Noha Abdel‐Wahab et al. · Cancer Cell · 2022 · 344 citations · Full text

Medicine, Immunology, Oncology +14

Bempegaldesleukin (NKTR-214) plus Nivolumab in Patients with Advanced Solid Tumors: Phase I Dose-Escalation Study of Safety, Efficacy, and Immune Activation (PIVOT-02)

Adi Diab, Nizar M. Tannir, Salah-Eddine Bentebibel et al. · Cancer Discovery · 2020 · 238 citations · Full text

Pharmacy, Oncology, Pharmacology +17

1–5 of 19